Formerly known as Zandu Chemicals Ltd, ZCL is in the active pharmaceutical ingredients or API space in India. The Parikh family had acquired ZCL from Zandu Pharmaceuticals Ltd in 2008 at an equity valuation of Rs 12.5 crore, the Parikh family said in a statement.
Nihar and his father Ajay Parikh had floated ZCL Chemicals when Zandu Pharma was acquired by Emami in 2008
Parikh family, founder and promoters of ZCL Chemicals Limited announced that they have sold the entire stake in the company to Advent International, one of the largest and most experienced global private equity investors, for an equity value of Rs. 2,000 crore.
ZCL Chemicals Ltd is all set to serve up benchmark returns for Morgan Stanley PE Asia as the investor gets ready to exit the active...
Bulk-drugs manufacturer ZCL Chemicals Ltd, which had initiated talks last year to provide Morgan Stanley Private Equity Asia with...
NSPIRA Management Services Pvt. Ltd, which offers services in the education sector, has raised $75 million (around Rs 515 crore) from Morgan Stanley’s private equity arm and mid-market PE firm BanyanTree Capital.
Stent maker Sahajanand Medical Technologies Pvt. Ltd has raised fresh capital of Rs 230 crore ($36.23 million) in a funding round led by new investor Morgan Stanley Private Equity Asia for an unspecified minority stake.
Morgan Stanley PE, BanyanTree pump $75 mn into education services firm NSPIRA
A round-up of developments in the API sector with news from Laurus, ZCL Chemicals and Johnson Matthey.
ZCL Chemicals announces successful US FDA Inspection with Zero 483 observations